Maxcyte (MXCT) Asset Utilization Ratio (2021 - 2026)

Maxcyte (MXCT) has 6 years of Asset Utilization Ratio data on file, last reported at 0.09 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 24.77% year-over-year to 0.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.09 (down 24.77% YoY) and the FY2025 annual result came in at 0.09, down 37.67% from the prior year.
• Asset Utilization Ratio rose to 0.09 in Q1 2026 per MXCT's latest filing, from 0.07 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.13 in Q2 2025 and bottomed at 0.06 in Q3 2023.
• The 5-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.09.
• The widest annual swing landed in 2022, when Asset Utilization Ratio surged 67.48%; it then slumped 41.66% in 2025.
• Tracing MXCT's Asset Utilization Ratio over 5 years: stood at 0.09 in 2022, then fell by 2.8% to 0.09 in 2023, then jumped by 31.07% to 0.11 in 2024, then tumbled by 41.66% to 0.07 in 2025, then surged by 34.84% to 0.09 in 2026.
• Per Business Quant, the three latest MXCT Asset Utilization Ratio figures stand at 0.09 (Q1 2026), 0.07 (Q4 2025), and 0.13 (Q3 2025).

Peer Comparison